Stimulation of mild, sustained ketonemia by medium-chain triacylglycerols in healthy humans: Estimated potential contribution to brain energy metabolism

Nutrition

Volumn 29, Issue 4, 2013, Pages 635-640

  Courchesne Loyer, Alexandre ^a,b   Fortier, Mélanie ^a   Tremblay Mercier, Jennifer ^a   Chouinard Watkins, Raphaël ^a,b   Roy, Maggie ^a,b   Nugent, Scott ^a,b   Castellano, Christian Alexandre ^a   Cunnane, Stephen C ^a,b  

^a UNIVERSITY INSTITUTE OF GERIATRICS OF SHERBROOKE   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

Brain; Ketone bodies; Medium chain triacylglycerols; Metabolism; Supplementation

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; CHOLESTEROL; FATTY ACID; GLUCOSE; INSULIN; KETONE; LACTIC ACID; MEDIUM CHAIN TRIACYLGLYCEROL; OCTANOIC ACID; TRIACYLGLYCEROL; TRIOCTANOATE; UNCLASSIFIED DRUG;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ARTICLE; BLOOD LEVEL; BRAIN METABOLISM; CHOLESTEROL BLOOD LEVEL; DIET SUPPLEMENTATION; DISEASE SEVERITY; ENERGY METABOLISM; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; KETOGENESIS; KETONE BLOOD LEVEL; KETONEMIA; LACTATE BLOOD LEVEL; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; SAFETY; TRIACYLGLYCEROL BLOOD LEVEL;

3-HYDROXYBUTYRIC ACID; ACETOACETATES; ADULT; BRAIN; CAPRYLATES; CARBON ISOTOPES; DIETARY SUPPLEMENTS; EMULSIONS; ENERGY METABOLISM; FEMALE; HUMANS; KETOGENIC DIET; KETOSIS; MALE; MOLECULAR WEIGHT; NEURONS; NOOTROPIC AGENTS; OXIDATION-REDUCTION; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 84875368921     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.09.009     Document Type: Article

References (34)

1. Cahill G.F. Fuel metabolism in starvation. Annu Rev Nutr 2006, 26:1-22.
2. Dahlquist G., Persson B. The rate of cerebral utilization of glucose, ketone bodies, and oxygen: a comparative in vivo study of infant and adult rats. Pediatr Res 1976, 10:910-917.
3. Fukao T., Lopaschuk G.D., Mitchell G.A. Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry. Prostaglandins Leukot Essent Fatty Acids 2004, 70:243-251.
4. Auestad N., Korsak R.A., Morrow J.W., Edmond J. Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J Neurochem 1991, 56:1376-1386.
5. Owen O.E., Morgan A.P., Kemp H.G., Sullivan J.M., Herrera M.G., Cahill G.F. Brain metabolism during fasting. J Clin Invest 1967, 46:1589-1595.
6. Simpson I.A., Carruthers A., Vannucci S.J. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. J Cereb Blood Flow Metab 2007, 27:1766-1791.
7. Bach A.C., Babayan V.K. Medium-chain triglycerides: an update. Am J Clin Nutr 1982, 36:950-962.
8. Freund G., Weinsier R.L. Standardized ketosis in man following medium chain triglyceride ingestion. Metabolism 1966, 15:980-991.
9. Reger M.A., Henderson S.T., Hale C., Cholerton B., Baker L.D., Watson G.S., et al. Effects of beta-hydroxybutyrate on cognition in memory-impaired adults. Neurobiol Aging 2004, 25:311-314.
10. Page K.A., Williamson A., Yu N., McNay E.C., Dzuira J., McCrimmon R.J., Sherwin R.S. Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes 2009, 58:1237-1244.
11. Freemantle E., Vandal M., Tremblay Mercier J., Plourde M., Poirier J., Cunnane S.C. Metabolic response to a ketogenic breakfast in the healthy elderly. J Nutr Health Aging 2009, 13:293-298.
12. Krikorian R., Shidler M.D., Dangelo K., Couch S.C., Benoit S.C., Clegg D.J. Dietary ketosis enhances memory in mild cognitive impairment. Neurobiol Aging 2012, 33:e419-e427.
13. Henderson S.T., Vogel J.L., Barr L.J., Garvin F., Jones J.J., Costantini L.C. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutr Metab (Lond) 2009, 6:31.
14. Blennow K., de Leon M.J., Zetterberg H. Alzheimer's disease. Lancet 2006, 368:387-403.
15. Mosconi L., Sorbi S., de Leon M.J., Li Y., Nacmias B., Myoung P.S., et al. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J Nucl Med 2006, 47:1778-1786.
16. Ogawa M., Fukuyama H., Ouchi Y., Yamauchi H., Kimura J. Altered energy metabolism in Alzheimer's disease. J Neurol Sci 1996, 139:78-82.
17. Cunnane S., Nugent S., Roy M., Courchesne-Loyer A., Croteau E., Tremblay S., et al. Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition 2011, 27:3-20.
18. Veech R.L., Chance B., Kashiwaya Y., Lardy H.A., Cahill G.F. Ketone bodies, potential therapeutic uses. IUBMB Life 2001, 51:241-247.
19. Henderson S.T. Ketone bodies as a therapeutic for Alzheimer's disease. Neurotherapeutics 2008, 5:470-480.
20. Neal E.G., Chaffe H., Schwartz R.H., Lawson M.S., Edwards N., Fitzsimmons G., et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol 2008, 7:500-506.
21. Caraballo R., Vaccarezza M., Cersosimo R., Rios V., Soraru A., Arroyo H., et al. Long-term follow-up of the ketogenic diet for refractory epilepsy: multicenter Argentinean experience in 216 pediatric patients. Seizure 2011, 20:640-645.
22. Balietti M., Casoli T., Di Stefano G., Giorgetti B., Aicardi G., Fattoretti P. Ketogenic diets: an historical antiepileptic therapy with promising potentialities for the aging brain. Ageing Res Rev 2010, 9:273-279.
23. Stafstrom C.E., Rho J.M. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 2012, 3:59.
24. Li P.K., Lee J.T., MacGillivray M.H., Schaefer P.A., Siegel J.H. Direct, fixed-time kinetic assays for beta-hydroxybutyrate and acetoacetate with a centrifugal analyzer or a computer-backed spectrophotometer. Clin Chem 1980, 26:1713-1717.
25. Harano Y., Ohtsuki M., Ida M., Kojima H., Harada M., Okanishi T., et al. Direct automated assay method for serum or urine levels of ketone bodies. Clin Chim Acta 1985, 151:177-183.
26. Tremblay-Mercier J., Tessier D., Plourde M., Fortier M., Lorrain D., Cunnane S.C. Bezafibrate mildly stimulates ketogenesis and fatty acid metabolism in hypertriglyceridemic subjects. J Pharmacol Exp Ther 2010, 334:341-346.
27. Gottstein U., Muller W., Berghoff W., Gartner H., Held K. [Utilization of non-esterified fatty acids and ketone nbodies in human brain]. Klin Wochenschr 1971, 49:406-411.
28. Settergren G., Lindblad B.S., Persson B. Cerebral blood flow and exchange of oxygen, glucose, ketone bodies, lactate, pyruvate and amino acids in infants. Acta Paediatr Scand 1976, 65:343-353.
29. Lying-Tunell U., Lindblad B.S., Malmlund H.O., Persson B. Cerebral blood flow and metabolic rate of oxygen, glucose, lactate, pyruvate, ketone bodies and amino acids. Acta Neurol Scand 1980, 62:265-275.
30. Lying-Tunell U., Lindblad B.S., Malmlund H.O., Persson B. Cerebral blood flow and metabolic rate of oxygen, glucose, lactate, pyruvate, ketone bodies and amino acids. Acta Neurol Scand 1981, 63:337-350.
31. Blomqvist G., Thorell J.O., Ingvar M., Grill V., Widen L., Stone-Elander S. Use of R-beta-[1-11C]hydroxybutyrate in PET studies of regional cerebral uptake of ketone bodies in humans. Am J Physiol Endocrinol Metab 1995, 269:E948-E959.
32. Blomqvist G., Alvarsson M., Grill V., Von Heijne G., Ingvar M., Thorell J.O., et al. Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab 2002, 283:E20-E28.
33. Hasselbalch S.G., Madsen P.L., Hageman L.P., Olsen K.S., Justesen N., et al. Changes in cerebral blood flow and carbohydrate metabolism during acute hyperketonemia. Am J Physiol Endocrinol Metab 1996, 270:E746-E751.
34. Cullingford T.E., Dolphin C.T., Sato H. The peroxisome proliferator-activated receptor alpha-selective activator ciprofibrate upregulates expression of genes encoding fatty acid oxidation and ketogenesis enzymes in rat brain. Neuropharmacology 2002, 42:724-730.